Geron Stock Last Dividend Paid
| GERN Stock | USD 4.12 0.05 1.20% |
Geron fundamentals help investors to digest information that contributes to Geron's financial success or failures. It also enables traders to predict the movement of Geron Stock. The fundamental analysis module provides a way to measure Geron's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Geron stock.
Geron | Last Dividend Paid |
Geron Company Last Dividend Paid Analysis
Geron's Last Dividend Paid refers to dividend per share(DPS) paid to the shareholder the last time dividends were issued by a company. In its conventional sense, dividends refer to the distribution of some of a company's net earnings or capital gains decided by the board of directors.
More About Last Dividend Paid | All Equity Analysis
Last Dividend | = | Last Profit Distribution AmountTotal Shares |
Geron Last Dividend Paid Driver Correlations
Understanding the fundamental principles of building solid financial models for Geron is extremely important. It helps to project a fair market value of Geron Stock properly, considering its historical fundamentals such as Last Dividend Paid. Since Geron's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Geron's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Geron's interrelated accounts and indicators.
Click cells to compare fundamentals
Many stable companies today pay out dividends to their shareholders in the form of the income distribution, but high-growth firms rarely offer dividends because all of their earnings are reinvested back to the business.
| Competition |
Based on the recorded statements, Geron has a Last Dividend Paid of 0.0. This indicator is about the same for the Biotechnology average (which is currently at 0.0) sector and about the same as Health Care (which currently averages 0.0) industry. This indicator is about the same for all United States stocks average (which is currently at 0.0).
Did you try this?
Run Sign In To Macroaxis Now
Sign In To MacroaxisSign in to explore Macroaxis' wealth optimization platform and fintech modules |
| All Next | Launch Module |
Geron ESG Sustainability
Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Geron's sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Geron's managers, analysts, and investors.Environmental | Governance | Social |
Geron Fundamentals
| Return On Equity | -0.69 | ||||
| Return On Asset | -0.3 | ||||
| Operating Margin | (1.00) % | ||||
| Current Valuation | 2.24 B | ||||
| Shares Outstanding | 604.5 M | ||||
| Shares Owned By Insiders | 0.08 % | ||||
| Shares Owned By Institutions | 85.36 % | ||||
| Number Of Shares Shorted | 70.13 M | ||||
| Price To Earning | (12.48) X | ||||
| Price To Book | 8.52 X | ||||
| Price To Sales | 85.51 X | ||||
| Revenue | 237 K | ||||
| Gross Profit | (93.67 M) | ||||
| EBITDA | (174.78 M) | ||||
| Net Income | (184.13 M) | ||||
| Cash And Equivalents | 219.29 M | ||||
| Cash Per Share | 0.58 X | ||||
| Total Debt | 85.9 M | ||||
| Debt To Equity | 0.39 % | ||||
| Current Ratio | 4.85 X | ||||
| Book Value Per Share | 0.48 X | ||||
| Cash Flow From Operations | (167.74 M) | ||||
| Short Ratio | 7.39 X | ||||
| Earnings Per Share | (0.32) X | ||||
| Price To Earnings To Growth | (2.38) X | ||||
| Target Price | 7.45 | ||||
| Number Of Employees | 141 | ||||
| Beta | 0.52 | ||||
| Market Capitalization | 2.52 B | ||||
| Total Asset | 394.08 M | ||||
| Retained Earnings | (1.6 B) | ||||
| Working Capital | 233.28 M | ||||
| Current Asset | 115.89 M | ||||
| Current Liabilities | 6.63 M | ||||
| Net Asset | 394.08 M |
About Geron Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Geron's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Geron using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Geron based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
When determining whether Geron offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Geron's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Geron Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Geron Stock: Check out Geron Piotroski F Score and Geron Altman Z Score analysis. To learn how to invest in Geron Stock, please use our How to Invest in Geron guide.You can also try the Sign In To Macroaxis module to sign in to explore Macroaxis' wealth optimization platform and fintech modules.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Geron. If investors know Geron will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Geron listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.32) | Revenue Per Share 0.047 | Quarterly Revenue Growth 171.384 | Return On Assets (0.30) | Return On Equity (0.69) |
The market value of Geron is measured differently than its book value, which is the value of Geron that is recorded on the company's balance sheet. Investors also form their own opinion of Geron's value that differs from its market value or its book value, called intrinsic value, which is Geron's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Geron's market value can be influenced by many factors that don't directly affect Geron's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Geron's value and its price as these two are different measures arrived at by different means. Investors typically determine if Geron is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Geron's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.